# Johanna H. M. Driessen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/johanna-h-m-driessen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,105 |
| Field | Bone health and osteoporosis research |
| h-index | 25 |
| i10-index | 55 |
| Last Known Institution | Maastricht University Medical Centre |
| OpenAlex ID | https://openalex.org/A5051231925 |
| ORCID iD | 0000-0002-4503-6408 |
| Works | 116 |

## Researcher papers

- [Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients](https://scholariq.org/papers/chlamydia-trachomatis-and-the-risk-of-pelvic-inflammatory-disease-ectopic/)
- [Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline Counts](https://scholariq.org/papers/stability-of-blood-eosinophils-in-patients-with-chronic-obstructive-pulmonary/)
- [Genetic variants in pre-eclampsia: a meta-analysis](https://scholariq.org/papers/genetic-variants-in-pre-eclampsia-a-meta-analysis/)
- [Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study](https://scholariq.org/papers/risk-of-hypoglycaemia-in-users-of-sulphonylureas-compared-with-metformin-in/)
- [Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis](https://scholariq.org/papers/bone-fracture-risk-is-not-associated-with-the-use-of-glucagon-like-peptide-1/)
- [Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic Drugs](https://scholariq.org/papers/use-of-glucagon-like-peptide-1-receptor-agonists-and-risk-of-fracture-as/)
- [Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study](https://scholariq.org/papers/impact-of-cumulative-exposure-to-high-dose-oral-glucocorticoids-on-fracture-risk/)
- [Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture](https://scholariq.org/papers/use-of-dipeptidyl-peptidase-4-inhibitors-for-type-2-diabetes-mellitus-and-risk/)
- [Secular trends in major osteoporotic fractures among 50+ adults in Denmark between 1995 and 2010](https://scholariq.org/papers/secular-trends-in-major-osteoporotic-fractures-among-50-adults-in-denmark/)
- [The epidemiology of fractures in Denmark in 2011](https://scholariq.org/papers/the-epidemiology-of-fractures-in-denmark-in-2011/)
- [The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: a nation-wide cohort study](https://scholariq.org/papers/the-use-of-sodium-glucose-co-transporter-2-inhibitors-or-glucagon-like-peptide-1/)
- [Incretin‐based therapy and the risk of diabetic foot ulcers and related events](https://scholariq.org/papers/incretin-based-therapy-and-the-risk-of-diabetic-foot-ulcers-and-related-events/)

## Researcher topics

- [Bone health and osteoporosis research](https://scholariq.org/topics/bone-health-and-osteoporosis-research/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Hip and Femur Fractures](https://scholariq.org/topics/hip-and-femur-fractures/)
- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)

## Researcher university

- [Maastricht University Medical Centre](https://scholariq.org/institutions/maastricht-university-medical-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.